Skip to main content

Prostate Cancer Radionuclide Imaging

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer

Definition

The main goal for prostate cancer imaging is to achieve a more accurate disease characterization with anatomic, functional, and molecular imaging modalities. Compared to conventional radiographic studies, radionuclide imaging provides complementary information about both function and metabolism of tumor cells. Today, a variety of radionuclide imaging probes and techniques are in clinical trials.

Characteristics

During the last decade, there has been a significant advancement in imaging of prostate cancer. Conventional imaging, which includes ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), is currently used to detect organ-confined or metastatic disease for staging of tumorsand determining prognosis. Today, the major goal for prostate cancer imaging is more accurate disease characterization with anatomic, functional, and molecular imaging modalities. Since prostate cancer is clinically a heterogeneous disease characterized by biologic behavior...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Hricak H, Choyke PL, Eberhardt S, Leibel SA, Scardino PT (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243:28–53

    Article  PubMed  Google Scholar 

  • Jadvar H (2009) Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging 8:56–64

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jadvar H (2015) Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analysis. Tomography 1:18–22

    Article  PubMed  PubMed Central  Google Scholar 

  • Koo PJ, Kwak JJ, Pokharel S, Choyke PL (2015) Novel Imaging of Prostate Cancer with MRI, MRI/US, and PET. Curr Oncol Rep 17:56

    Article  PubMed  Google Scholar 

  • Lawrentschuk N, Davis ID, Bolton DM, Scott AM (2006) Positron emission tomography and molecular imaging of the prostate: an update. BJU Int 97:923–931

    Article  CAS  PubMed  Google Scholar 

  • Ravizzini G, Turkbey B, Kurdziel K, Choyke PL (2009) New horizons in prostate cancer imaging. Eur J Radiol 70:212–226

    Article  PubMed  Google Scholar 

  • Rossi PJ, Schuster DM (2015) Molecular imaging of advanced prostate cancer. Curr Probl Cancer 39:29–32

    Article  PubMed  Google Scholar 

  • Zaheer A, Cho SY, Pomper MG (2009) New agent and techniques for imaging prostate cancer. J Nucl Med 50:1387–1390

    Article  CAS  PubMed  PubMed Central  Google Scholar 

See Also

  • (2012) Adjuvant. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 75. doi:10.1007/978-3-642-16483-5_107

    Google Scholar 

  • (2012) Computed Tomography. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 964–965. doi:10.1007/978-3-642-16483-5_1295

    Google Scholar 

  • (2012) Epithelial Cell. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 1291–1292. doi:10.1007/978-3-642-16483-5_1958

    Google Scholar 

  • (2012) Epitope. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1297. doi:10.1007/978-3-642-16483-5_1966

    Google Scholar 

  • (2012) Glycoprotein. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1570. doi:10.1007/978-3-642-16483-5_2451

    Google Scholar 

  • (2012) Imaging. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1808. doi:10.1007/978-3-642-16483-5_6509

    Google Scholar 

  • (2012) Integrin. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1884. doi:10.1007/978-3-642-16483-5_3084

    Google Scholar 

  • (2012) Magnetic Resonance Imaging. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2136. doi:10.1007/978-3-642-16483-5_3496

    Google Scholar 

  • (2012) Monoclonal Antibody Therapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2367–2368. doi:10.1007/978-3-642-16483-5_3823

    Google Scholar 

  • (2012) Prognosis. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2994. doi:10.1007/978-3-642-16483-5_4758

    Google Scholar 

  • (2012) Promoter. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4768

    Google Scholar 

  • (2012) Radiation Therapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3144. doi:10.1007/978-3-642-16483-5_4907

    Google Scholar 

  • (2012) Scintigraphy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3341. doi:10.1007/978-3-642-16483-5_5179

    Google Scholar 

  • (2012) Ultrasound. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3836. doi:10.1007/978-3-642-16483-5_6097

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yiyan Liu .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Liu, Y. (2014). Prostate Cancer Radionuclide Imaging. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_6795-3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_6795-3

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics